By Brevetti Angela…
To get in touch with Brevetti Angela Srl, simply fill out the form below.
Subscribe to Supplier
Brevetti Angela and 3CK joint presence at PDA Universe of Pre-Filled Syringes Conference
Vicenza, Italy: – Leading manufacturer of Blow-Fill-Seal (BFS) pharma packaging machinery, Brevetti Angela Srl, and prefillable syringe specialist 3CK will again form a significant joint presence at the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference, celebrating its 20th anniversary in the Swedish city of Gothenburg (Göteborg).
Brevetti Angela has been a consistent presence at PDA-organised events for more than a decade, underlining its status as a leading force in parenteral pharma packaging. Since 2022, it has been joined by sister company 3CK as an innovator in the specific field of pre-filled and pre-fillable plastic syringes.
History of Parenteral Innovation
Brevetti Angela and 3CK will exhibit with a compact display at Tabletop 55 in the Exhibition Zone at the Swedish Exhibition & Congress Centre, at Gothenburg’s Gothia Towers Hotel. This will highlight 3CK’s industry-leading range of prefilled syringes that continues a long history of innovation from Brevetti Angela in the areas of parenteral packaging and aseptic filling, using Blow-Fill-Seal (BFS) technology injection devices.
Brevetti Angela was first to propose a squeezable prefilled syringe formed by BFS during the 1990s and will use the 2023 PDA meeting to show what is now possible for small vials formed in its SYFPAC machines, along with the 3CK prefillable syringes with their O-Flow technology to make them silicon-free, with working samples on display.
The Brevetti Angela and 3CK team at the 20th Anniversary event will include Ing. Rajeev Kabbur, sales and R&D director, who has been a driving force in the development of the 3CK technology.
About Brevetti Angela
Brevetti Angela Srl is one of the world’s leading manufacturers of pharma primary packaging machinery, specializing in production of Blow Fill Seal (BFS) machinery for the aseptic packing of liquids in purpose formed plastic bottles, vials and parenteral forms. Brevetti Angela platforms are ideally suited to aseptic filling of pharmaceutical solutions and can also be applied to food & beverages, cosmetics or cyanoacrylates filling.
Founded by Francesco Consolaro in 1977, the company remains based in Arzignano, in the province of Vicenza in north-eastern Italy. Over more than four decades, Brevetti Angela has been guided by a vision of following a path of continuous innovation based on ensuring customer satisfaction and quality of finished product, with a mission to provide primary packaging solutions that are flexible, versatile, and also reliable and easy to maintain.
The company is particularly known for its range of advanced and patented SYFPAC® BFS machines designed and engineered to achieve the highest quality aseptic packaging of sterile pharmaceutical fluids for small volume vials, bottles, and pre-filled syringes.
One of the key enablers for very high quality at Brevetti Angela is its emphasis on keeping all vital processes ‘in house’ at Arzignano where all facilities meet CE standards and since 2008 have been certificated to ISO 9001:2008 quality standards.
About 2023 PDA Universe Conference
Building on the success of past US Parenteral Drug Association events, the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference focuses on celebrating the latest advances in pre-fillable syringe technology and applications.
Themed ‘20 Years of Innovation in Drug Delivery – What’s Next?, the Universe of Pre-Filled Syringes conference is a two-day event opening October 18 at the The Swedish Exhibition & Congress Centre, part of the Gothia Towers Hotel in Gothenburg.
The conference is exploring diverse aspects of drug delivery, focusing on topics such as delivery of novel therapeutics, digital health, and sustainability.
The event is organized by the PDA Parenteral Drug Association with further information at:
Click on O-Flow: The Next Generation of Pre-Filled Syringes for further information from 3CK.